dbSNP id | CARD15Position | MAF case | MAF cont | ORallelic[CI95%] | Pallelic | PHAP2 | PHAP3 | PHAP4 | PHAP5 |
---|---|---|---|---|---|---|---|---|---|
1044 CRC patients vs 724 sex-matched control individuals | |||||||||
   rs5743266 | 5'UTR | 0.30 | 0.29 | 1.05 [0.91-1.22] | 0.459 | 0.687 | 0.236 | 0.362 | 0.517 |
   rs13339578 | intron | 0.30 | 0.30 | 0.99 [0.86-1.15] | 0.980 | 0.835 | 0.903 | 0.443 | 0.209 |
   rs2066844 | R702W | 0.05 | 0.05 | 1.13 [0.82-1.55] | 0.501 | 0.838 | 0.391 | 0.323 | 0.317 |
   rs2066845 | G908R | 0.01 | 0.01 | 1.27 [0.70-2.30] | 0.432 | 0.353 | 0.269 | 0.266 | 0.169 |
   rs5743289 | intron | 0.18 | 0.17 | 1.11 [0.93-1.33] | 0.247 | 0.103 | 0.151 | 0.132 | -# |
   rs5743291 | I955V | 0.08 | 0.10 | 0.80 [0.64-1.01] | 0.052 | 0.041 | 0.121 | -# | -# |
   rs2066847 | L1007fs | 0.04 | 0.03 | 1.31 [0.89-1.93] | 0.171 | 0.295 | -# | -# | -# |
   rs8056611 | 3'flank. region | 0.49 | 0.49 | 1.02 [0.89-1.17] | 0.823 | -# | -# | -# | -# |
143 CRC patients (age at diagnosis ≤50) vs 639 sex-matched control individuals | |||||||||
   rs5743266 | 5'UTR | 0.31 | 0.29 | 1.11 [0.84-1.47] | 0.456 | 0.232 | 0.196 | 0.232 | 0.323 |
   rs13339578 | intron | 0.32 | 0.3 | 1.09 [0.83-1.44] | 0.521 | 0.070 | 0.145 | 0.106 | 0.153 |
   rs2066844 | R702W | 0.08 | 0.05 | 1.75 [1.05-2.91] | 0.029 a | 0.03 | 0.117 | 0.210 | 0.228 |
   rs2066845 | G908R | 0.02 | 0.01 | 1.69 [0.66-4.36] | 0.273 | 0.161 | 0.305 | 0.275 | 0.281 |
   rs5743289 | intron | 0.21 | 0.17 | 1.29 [0.94-1.78] | 0.118 | 0.323 | 0.185 | 0.183 | -# |
   rs5743291 | I955V | 0.08 | 0.1 | 0.74 [0.46-1.19] | 0.214 | 0.116 | 0.598 | -# | -# |
   rs2066847 | L1007fs | 0.04 | 0.03 | 1.42 [0.71-2.83] | 0.316 | 0.613 | -# | -# | -# |
   rs8056611 | 3'flank. region | 0.5 | 0.48 | 1.05 [0.81-1.36] | 0.692 | -# | -# | -# | -# |